Skip to main content

Table 1 Clinical characteristics of the cohort

From: An impact of lipid profile and lipid lowering drugs on ≥70 year olds of an upper socioeconomic class: a retrospective cohort study

Clinical characteristics Men Women   P value
Median age (mean) 75 (76.5) 75 (76.5)   
Hypertension (%) 1037 (67.2) 282 (50.3)   < 0.001
Diabetes mellitus (%) 422 (28.2) 70 (12.5)   < 0.001
Dyslipidemia (%) 1187 (79.2) 418 (74.5)   0.021
Smoking* (past/active) (%) 811 (54.1) 230 (41.0)   < 0.001
Ischemic heart disease (%) 466 (31.1) 24 (4.3)   < 0.001
Stroke (%) 61 (4.1) 14 (2.5)   0.089
Cognitive decline (%) 88 (5.8) 35 (6.2)   0.756
Obstructive lung disease (%) 37 (2.5) 8 (1.4)   0.149
Chronic renal failure (%) 368 (24.6) 53 (9.5)   < 0.001
Atrial fibrillation (%) 165 (11.0) 33 (5.9)   < 0.001
Solid malignancy (%) 372 (24.9) 124 (22.1)   0.192
Hematological malignancy (%) 75 (5.0) 23 (4.1)   0.386
Any malignancy (%) 429 (28.6) 139 (24.8)   0.081
Colonic polypectomy (%) 597 (39.9) 164 (29.2)   < 0.001
Lipid lowering drug use > 3 years (%) 1077 (71.9) 344 (61.3)   < 0.001
Anti-platelet therapy (%) 772 (49.7) 140 (24.9)   < 0.001
Anti-coagulant therapy (%) 173 (11.6) 35 (6.2)   < 0.001
Death (%) 46 (3.1) 5 (0.9)   0.005
  1. Abbreviations: M Males, F Females
  2. *107 (7.1%) men and 30 (5.3%) women actively smoked, 704 (46.9%) men and 200 (35.7%) women were past smokers, 687 (45.9%) men, and 331 women never smoked (59.0%)